These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 38488852)
1. Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor. Jablonowski CM; Quarni W; Singh S; Tan H; Bostanthirige DH; Jin H; Fang J; Chang TC; Finkelstein D; Cho JH; Hu D; Pagala V; Sakurada SM; Pruett-Miller SM; Wang R; Murphy A; Freeman K; Peng J; Davidoff AM; Wu G; Yang J Elife; 2024 Mar; 12():. PubMed ID: 38488852 [TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor. Jablonowski C; Quarni W; Singh S; Tan H; Bostanthirige DH; Jin H; Fang J; Chang TC; Finkelstein D; Cho JH; Hu D; Pagala V; Sakurada SM; Pruett-Miller SM; Wang R; Murphy A; Freeman K; Peng J; Davidoff AM; Wu G; Yang J bioRxiv; 2023 Nov; ():. PubMed ID: 37425900 [TBL] [Abstract][Full Text] [Related]
3. JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner. Yi J; Shen HF; Qiu JS; Huang MF; Zhang WJ; Ding JC; Zhu XY; Zhou Y; Fu XD; Liu W Nucleic Acids Res; 2017 Apr; 45(6):3503-3518. PubMed ID: 27899633 [TBL] [Abstract][Full Text] [Related]
4. Jumonji domain containing protein 6 (Jmjd6) modulates splicing and specifically interacts with arginine-serine-rich (RS) domains of SR- and SR-like proteins. Heim A; Grimm C; Müller U; Häußler S; Mackeen MM; Merl J; Hauck SM; Kessler BM; Schofield CJ; Wolf A; Böttger A Nucleic Acids Res; 2014 Jul; 42(12):7833-50. PubMed ID: 24914048 [TBL] [Abstract][Full Text] [Related]
5. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis. Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402 [TBL] [Abstract][Full Text] [Related]
6. JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma. Wong M; Sun Y; Xi Z; Milazzo G; Poulos RC; Bartenhagen C; Bell JL; Mayoh C; Ho N; Tee AE; Chen X; Li Y; Ciaccio R; Liu PY; Jiang CC; Lan Q; Jayatilleke N; Cheung BB; Haber M; Norris MD; Zhang XD; Marshall GM; Wang JY; Hüttelmaier S; Fischer M; Wong JWH; Xu H; Perini G; Dong Q; George RE; Liu T Nat Commun; 2019 Jul; 10(1):3319. PubMed ID: 31346162 [TBL] [Abstract][Full Text] [Related]
7. JMJD6 Regulates Splicing of Its Own Gene Resulting in Alternatively Spliced Isoforms with Different Nuclear Targets. Raguz N; Heim A; Engal E; Wesche J; Merl-Pham J; Hauck SM; Erkelenz S; Schaal H; Bensaude O; Wolf A; Salton M; Böttger A Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927736 [TBL] [Abstract][Full Text] [Related]
8. JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component. Liu X; Si W; Liu X; He L; Ren J; Yang Z; Yang J; Li W; Liu S; Pei F; Yang X; Sun L Mol Cancer; 2017 Nov; 16(1):175. PubMed ID: 29187213 [TBL] [Abstract][Full Text] [Related]
9. The polyserine domain of the lysyl-5 hydroxylase Jmjd6 mediates subnuclear localization. Wolf A; Mantri M; Heim A; Müller U; Fichter E; Mackeen MM; Schermelleh L; Dadie G; Leonhardt H; Vénien-Bryan C; Kessler BM; Schofield CJ; Böttger A Biochem J; 2013 Aug; 453(3):357-70. PubMed ID: 23688307 [TBL] [Abstract][Full Text] [Related]
10. Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production. Palmer KR; Tong S; Tuohey L; Cannon P; Ye L; Hannan NJ; Brownfoot FC; Illanes SE; Kaitu'u-Lino TJ Biol Reprod; 2016 Mar; 94(3):59. PubMed ID: 26819475 [TBL] [Abstract][Full Text] [Related]
11. Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma. Nijhuis A; Sikka A; Yogev O; Herendi L; Balcells C; Ma Y; Poon E; Eckold C; Valbuena GN; Xu Y; Liu Y; da Costa BM; Gruet M; Wickremesinghe C; Benito A; Kramer H; Montoya A; Carling D; Want EJ; Jamin Y; Chesler L; Keun HC Nat Commun; 2022 Mar; 13(1):1380. PubMed ID: 35296644 [TBL] [Abstract][Full Text] [Related]
12. Protein arginine methylation/demethylation and cancer. Poulard C; Corbo L; Le Romancer M Oncotarget; 2016 Oct; 7(41):67532-67550. PubMed ID: 27556302 [TBL] [Abstract][Full Text] [Related]
13. Biochemical and structural investigations clarify the substrate selectivity of the 2-oxoglutarate oxygenase JMJD6. Islam MS; McDonough MA; Chowdhury R; Gault J; Khan A; Pires E; Schofield CJ J Biol Chem; 2019 Jul; 294(30):11637-11652. PubMed ID: 31147442 [TBL] [Abstract][Full Text] [Related]
14. Insights into Jumonji C-domain containing protein 6 (JMJD6): a multifactorial role in foot-and-mouth disease virus replication in cells. Lawrence P; Rieder E Virus Genes; 2017 Jun; 53(3):340-351. PubMed ID: 28364140 [TBL] [Abstract][Full Text] [Related]
15. A specific JMJD6 inhibitor potently suppresses multiple types of cancers both in vitro and in vivo. Xiao RQ; Ran T; Huang QX; Hu GS; Fan DM; Yi J; Liu W Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2200753119. PubMed ID: 35969736 [TBL] [Abstract][Full Text] [Related]
16. Differential regulation of sFlt-1 splicing by U2AF65 and JMJD6 in placental-derived and endothelial cells. Eddy AC; Chapman H; Brown DT; George EM Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32039444 [TBL] [Abstract][Full Text] [Related]
17. Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models. Singh S; Quarni W; Goralski M; Wan S; Jin H; Van de Velde LA; Fang J; Wu Q; Abu-Zaid A; Wang T; Singh R; Craft D; Fan Y; Confer T; Johnson M; Akers WJ; Wang R; Murray PJ; Thomas PG; Nijhawan D; Davidoff AM; Yang J Sci Adv; 2021 Nov; 7(47):eabj5405. PubMed ID: 34788094 [TBL] [Abstract][Full Text] [Related]
18. The oxygenase Jmjd6--a case study in conflicting assignments. Böttger A; Islam MS; Chowdhury R; Schofield CJ; Wolf A Biochem J; 2015 Jun; 468(2):191-202. PubMed ID: 25997831 [TBL] [Abstract][Full Text] [Related]
19. Jumonji domain-containing protein 6 protein and its role in cancer. Yang J; Chen S; Yang Y; Ma X; Shao B; Yang S; Wei Y; Wei X Cell Prolif; 2020 Feb; 53(2):e12747. PubMed ID: 31961032 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of JMJD6 by 2-Oxoglutarate Mimics. Islam MS; Thinnes CC; Holt-Martyn JP; Chowdhury R; McDonough MA; Schofield CJ ChemMedChem; 2022 Jan; 17(1):e202100398. PubMed ID: 34581506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]